£69.00
BPC-157 TB500 Blend 20mg — lyophilised dual-peptide research compound, ≥99% purity, supplied as a white powder in a sealed vial. Contains 10mg BPC-157 (CAS 137525-51-0, MW 1,419.5 g/mol) and 10mg TB-500 (CAS 885340-08-9, MW 4,963.4 g/mol), formulated at a 1:1 ratio for extended tissue repair, angiogenesis, and cytoskeletal remodelling research. Certificate of Analysis available. For research use only.
25 people are viewing this product right now
🔥 5 items sold in last 3 hours
BPC-157 TB500 Blend 20mg is a lyophilised dual-peptide research compound supplied as a white powder in a sealed vial, containing 10mg of BPC-157 and 10mg of TB-500 at a 1:1 ratio. This high-yield 20mg format is intended for preclinical studies requiring extended investigation of combined peptide activity across multiple biological pathways. BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid gastric pentadecapeptide with molecular formula C₂H₉₈N₁₆O₂₂, molecular weight 1,419.535 g/mol, and CAS number 137525-51-0 (PubChem CID 9941957). TB-500 is a synthetic fragment of Thymosin Beta-4, a 43-amino acid protein with molecular formula C₂₁₂H₃₅₀N₅₆O₇₈S, molecular weight 4,963.44 g/mol, and CAS number 885340-08-9 (PubChem CID 62707662). All batches of BPC-157 TB500 Blend 20mg are independently verified at ≥99% purity by HPLC and mass spectrometry — results available on our Certificate of Analysis page. For research use only.
The BPC-157 TB500 Blend 20mg provides researchers with two mechanistically distinct peptides in a single, high-concentration formulation. BPC-157 exerts its primary effects through growth hormone receptor (GHR) upregulation in tendon fibroblasts, VEGFR2-mediated angiogenesis, nitric oxide pathway modulation, and collagen synthesis stimulation. TB-500 acts via a fundamentally different mechanism: it sequesters G-actin through its conserved LKKTET motif, regulating cytoskeletal dynamics to drive cell migration, proliferation, and differentiation at injury sites. By combining both compounds at equal doses, the BPC-157 TB500 Blend 20mg allows researchers to simultaneously investigate complementary repair signalling without running parallel experiments on separate cohorts — reducing both experimental complexity and material cost per study.
BPC-157 has been extensively studied in in vivo models of tendon, ligament, muscle, bone, and gastrointestinal tissue injury. It is notable for its high chemical stability — unlike many peptides, BPC-157 retains activity across a wide pH range and in the presence of gastric acid. Published preclinical data indicates upregulation of early growth response protein 1 (EGR1) in fibroblast cultures, accelerated collagen type I deposition, and promotion of blood vessel formation in wound bed models. A comprehensive review of BPC-157’s healing mechanisms is available on PubMed Central (PMC8228050).
TB-500 is the 17-23 amino acid fragment of Thymosin Beta-4 (Tβ4), a ubiquitous actin-sequestering protein expressed in virtually all mammalian cells at high concentrations. As the biologically active domain of the full-length protein, TB-500 retains the capacity to upregulate cell-surface actin, promote angiogenesis, reduce acute and chronic inflammation, and support cardiac and skeletal muscle repair in preclinical models. Research published in Applied Sciences (2026) provides a current scoping review of TB-500 and Thymosin Beta-4 across tissue healing, regeneration, and musculoskeletal repair models, confirming its continued relevance as a research peptide.
The BPC-157 TB500 Blend 20mg is suited to research protocols requiring larger sample sets, longer-duration study windows, or dose-escalation designs. At 10mg per peptide component, the BPC-157 TB500 Blend 20mg allows researchers to prepare a greater number of reconstituted aliquots from a single vial compared to the 10mg format, improving batch-to-batch consistency and reducing reconstitution frequency. The lyophilised powder format ensures stability during storage and extends usable shelf life when kept at −20°C. Researchers running comparative studies between isolated peptides and the BPC-157 TB500 Blend 20mg will find the higher vial content particularly advantageous for multi-arm experimental designs.
Store BPC-157 TB500 Blend 20mg lyophilised powder at −20°C, protected from light and moisture. Reconstitute using bacteriostatic water or sterile saline immediately prior to use. Once reconstituted, store at 4°C and use within 28 days. Do not refreeze reconstituted solution. Handle under sterile laboratory conditions. This compound is not approved for human or veterinary use.
| Parameter | BPC-157 | TB-500 |
|---|---|---|
| CAS Number | 137525-51-0 | 885340-08-9 |
| Molecular Weight | 1,419.535 g/mol | 4,963.44 g/mol |
| PubChem CID | 9941957 | 62707662 |
| Sequence Length | 15 amino acids | 17 amino acids (fragment) |
| Purity | ≥99% (HPLC verified) | |
| Vial Content | 10mg | 10mg |
| Total Blend | 20mg lyophilised powder | |
| Storage | −20°C, away from light and moisture | |
| Reconstitution | Bacteriostatic water or sterile saline | |
{“@context”:”https://schema.org”,”@type”:”MedicalWebPage”,”name”:”BPC-157 & TB500 BLEND Research Information”,”url”:”https://armapeptides.com/product/bpc-157-tb500-blend-20mg/”,”speakable”:{“@type”:”SpeakableSpecification”,”cssSelector”:[“.product-short-description”,”.woocommerce-product-details__short-description”,”h1″,”.entry-summary”]},”citation”:[{“@type”:”CreativeWork”,”name”:”BPC-157 research on PubMed”,”url”:”https://pubmed.ncbi.nlm.nih.gov/30030193/”},{“@type”:”CreativeWork”,”name”:”BPC-157 overview on Examine.com”,”url”:”https://examine.com/supplements/bpc-157/”}],”about”:{“@type”:”Drug”,”name”:”BPC-157 & TB500 BLEND”,”description”:”BPC-157 & TB500 BLEND is a research peptide available in the UK from Arma Peptides with ≥99% purity.”}}
{
“@context”: “https://schema.org”,
“@type”: “Product”,
“@id”: “https://armapeptides.com/product/bpc-157-tb500-blend-20mg/#product”,
“name”: “BPC-157 & TB500 BLEND 20MG”,
“description”: “BPC-157 TB500 Blend 20mg — lyophilised dual-peptide research compound, ≥99% purity, supplied as a white powder in a sealed vial. Contains 10mg BPC-157 (CAS 137525-51-0, MW 1,419.5 g/mol) and 10mg TB-500 (CAS 885340-08-9, MW 4,963.4 g/mol), formulated at a 1:1 ratio for extended tissue repair, angiogenesis, and cytoskeletal remodelling research. Certificate of Analysis available. For research use only.”,
“url”: “https://armapeptides.com/product/bpc-157-tb500-blend-20mg/”,
“brand”: {
“@type”: “Brand”,
“name”: “Arma Peptides”
},
“offers”: {
“@type”: “Offer”,
“price”: “69”,
“priceCurrency”: “GBP”,
“priceValidUntil”: “2027-12-31”,
“availability”: “https://schema.org/InStock”,
“itemCondition”: “https://schema.org/NewCondition”,
“url”: “https://armapeptides.com/product/bpc-157-tb500-blend-20mg/”,
“seller”: {
“@type”: “Organization”,
“name”: “Arma Peptides”,
“url”: “https://armapeptides.com”
},
“shippingDetails”: {
“@type”: “OfferShippingDetails”,
“shippingRate”: {
“@type”: “MonetaryAmount”,
“value”: “0”,
“currency”: “GBP”
},
“shippingDestination”: {
“@type”: “DefinedRegion”,
“addressCountry”: “GB”
},
“deliveryTime”: {
“@type”: “ShippingDeliveryTime”,
“handlingTime”: {
“@type”: “QuantitativeValue”,
“minValue”: 0,
“maxValue”: 1,
“unitCode”: “DAY”
},
“transitTime”: {
“@type”: “QuantitativeValue”,
“minValue”: 1,
“maxValue”: 3,
“unitCode”: “DAY”
}
}
}
},
“hasMerchantReturnPolicy”: {
“@type”: “MerchantReturnPolicy”,
“applicableCountry”: “GB”,
“returnPolicyCategory”: “https://schema.org/MerchantReturnFiniteReturnWindow”,
“merchantReturnDays”: 30,
“returnMethod”: “https://schema.org/ReturnByMail”,
“returnFees”: “https://schema.org/FreeReturn”
},
“image”: “https://armapeptides.com/wp-content/uploads/2026/06/BPC-157-TB500-20mg.png”
}
£34.00
£65.00
Reviews
There are no reviews yet.